Omega Healthcare Investors, Inc. (OHI) Tops Q2 FFO by 2c, Narrows FY11 FFO Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts OHI Hot Sheet
Price: $46.98 +0.30%
EPS Growth %: -20.3%
Financial Fact:
Interest - amortization of deferred financing costs: -2.5M
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -20.3%
Financial Fact:
Interest - amortization of deferred financing costs: -2.5M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Omega Healthcare Investors, Inc. (NYSE: OHI) reported Q2 EPS of $0.47, $0.02 better than the analyst estimate of $0.45. Revenue for the quarter came in at $72.6 million versus the consensus estimate of $69.84 million.
Omega Healthcare Investors, Inc. sees FY2011 adjusted FFO of $1.82-$1.86, versus prior guidance of $1.80-$1.86 and the consensus of $1.76.
Omega Healthcare Investors, Inc. sees FY2011 adjusted FFO of $1.82-$1.86, versus prior guidance of $1.80-$1.86 and the consensus of $1.76.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- Oppenheimer Holdings (OPY) Reports Q3 EPS of $1.81
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
